PMID- 20159976 OWN - NLM STAT- MEDLINE DCOM- 20100504 LR - 20240419 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 285 IP - 15 DP - 2010 Apr 9 TI - Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. PG - 11270-80 LID - 10.1074/jbc.M109.093658 [doi] AB - The plasma membrane serotonin (5-HT) transporter (SERT, SLC6A4) clears 5-HT after release at nerve termini and is targeted by both antidepressant medications and psychostimulants (e.g. MDMA, cocaine). Homology modeling of human SERT (hSERT), based on high resolution structures of the microbial SLC6 family member LeuT(Aa), along with biochemical studies of wild type and mutant transporters, predicts transmembrane (TM) domains 1, 3, 6, and 8 comprise the 5-HT-binding pocket. We utilized the substituted cysteine accessibility method along with surface and site-specific biotinylation to probe TM6 for aqueous accessibility and differential interactions with 5-HT and psychostimulants. Our results are consistent with TM6 being composed of an aqueous-accessible, alpha-helical extracellular domain (TM6a) that is separated by a central, unwound section from a cytoplasmically localized domain (TM6b) with limited aqueous accessibility. The substitution G338C appears to lock hSERT in an outward-facing conformation that, although accessible to aminoethylmethanethiosulfonate-biotin, 5-HT, and citalopram, is incapable of inward 5-HT transport. Transport of 5-HT by G338C can be partially restored by the TM1 mutation Y95F. With regard to methanethiosulfonate (MTS) inactivation of uptake, TM6a Cys mutants demonstrate Na(+)-dependent [2-(trimethylammonium)ethyl]-MTS sensitivity. Studies with the centrally located substitution S336C reveal features of a common binding pocket for 5-HT and 3,4-methylenedioxymethamphetamine (MDMA). Interestingly, the substitution I333C reveals an MDMA-induced conformation not observed with 5-HT. In the context of prior studies on TM1, our findings document shared and unique features of TM6 contributing to hSERT aqueous accessibility, ligand recognition, and conformational dynamics. FAU - Field, Julie R AU - Field JR AD - Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8548, USA. FAU - Henry, L Keith AU - Henry LK FAU - Blakely, Randy D AU - Blakely RD LA - eng GR - R01 DA007390/DA/NIDA NIH HHS/United States GR - K01 DA022378/DA/NIDA NIH HHS/United States GR - DA07390/DA/NIDA NIH HHS/United States GR - DA022378/DA/NIDA NIH HHS/United States GR - F31 DA023337/DA/NIDA NIH HHS/United States GR - DA23337/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20100216 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (SLC6A4 protein, human) RN - 0 (Serotonin Agents) RN - 0 (Serotonin Plasma Membrane Transport Proteins) RN - 059QF0KO0R (Water) RN - 333DO1RDJY (Serotonin) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Biological Transport MH - Cytoplasm/metabolism MH - Humans MH - Kinetics MH - Models, Biological MH - Mutagenesis, Site-Directed MH - Mutation MH - N-Methyl-3,4-methylenedioxyamphetamine/pharmacology MH - Protein Binding MH - Protein Conformation MH - Protein Structure, Tertiary MH - Serotonin/*chemistry MH - Serotonin Agents/pharmacology MH - Serotonin Plasma Membrane Transport Proteins/*chemistry/*metabolism MH - Water/chemistry PMC - PMC2857005 EDAT- 2010/02/18 06:00 MHDA- 2010/05/05 06:00 PMCR- 2011/04/09 CRDT- 2010/02/18 06:00 PHST- 2010/02/18 06:00 [entrez] PHST- 2010/02/18 06:00 [pubmed] PHST- 2010/05/05 06:00 [medline] PHST- 2011/04/09 00:00 [pmc-release] AID - S0021-9258(19)40577-2 [pii] AID - M109.093658 [pii] AID - 10.1074/jbc.M109.093658 [doi] PST - ppublish SO - J Biol Chem. 2010 Apr 9;285(15):11270-80. doi: 10.1074/jbc.M109.093658. Epub 2010 Feb 16.